FIG. 1.
Ebselen reduces diabetes-associated atherosclerosis in the ApoE−/−GPx1−/− (dKO) aorta. Sudan IV-stained aortas from (A) nondiabetic, (B) diabetic, and (C) ebselen-gavaged diabetic dKO mice, 20 weeks after sham or streptozotocin-induced diabetes. Total and regional plaque is shown in D and E, respectively; Bars, mean ± SEM (n = 6–10 aortas/group). ***P < 0.001, **P < 0.01 vs. nondiabetic controls; ###P < 0.001, ##P < 0.01, #P < 0.05 vs. diabetic dKO aortas. Abd, abdominal; D, diabetic; Eb, ebselen; ND, nondiabetic; Thor, thoracic. (A high-quality digital representation of this figure is available in the online issue.)